Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0R1B

Biogen (0R1B)

Biogen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0R1B
DateTimeSourceHeadlineSymbolCompany
03/06/20246:30AMUK RegulatoryNew Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene TherapyLSE:0R1BBiogen Inc
03/04/20243:15PMUK RegulatoryBiogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual MeetingLSE:0R1BBiogen Inc
02/23/20246:00AMUK RegulatoryBiogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMPLSE:0R1BBiogen Inc
02/12/20243:06PMUK RegulatoryBiogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s AtaxiaLSE:0R1BBiogen Inc
01/31/20246:30AMUK RegulatoryBiogen to Realign Resources for Alzheimer's Disease FranchiseLSE:0R1BBiogen Inc
08/06/202311:07AMAlliance NewsAlliance NewsCORRECT: Biogens, Sage Therapeutics postpartum depression drug okayedLSE:0R1BBiogen Inc
08/06/20238:17AMAlliance NewsAlliance NewsBiogens, Sage Therapeutics postpartum depression treatment approvedLSE:0R1BBiogen Inc
06/09/20236:12AMAlliance NewsAlliance News*Nasdaq halts trading of Biogen stockLSE:0R1BBiogen Inc
01/13/20208:28AMAlliance NewsAlliance NewsPfizer Could Net USD635 Million As Biogen Acquires Alzheimer's DrugLSE:0R1BBiogen Inc
 Showing the most relevant articles for your search:LSE:0R1B